Karyopharm Therapeutics Inc. — insider transactions

2 transactions on record · KPTI · CIK 1503802

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
2
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
1
Bought, 3m
$0
Sold, 3m
$2.1K
Median disclosure lag
2.0 d
trade date to filing date
Largest single trade, 24m
$1.6K
2026-10-16
Director share, 12m
0.0%
of transactions where role is stated
Current run
2 sells
consecutive same-direction transactions
Net 3m flow
-$2.1K
purchases minus sales
Total on record
2

Transactions

2 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-10-192026-10-163Abate KristinChief Accounting OfficerOpen market sale4,788$0.34$1.6Kfiling
2026-10-022026-10-011Abate KristinChief Accounting OfficerOpen market sale378$1.19$449.8filing

Source: U.S. Securities and Exchange Commission, EDGAR

Karyopharm Therapeutics Inc. insider transactions — 2 filings on record — investment.com